Organism name | Thymus vulgaris |
---|---|
Genus | Thymus |
Family | Labiatae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Thymus vulgaris |
---|---|
Linked NCBI taxonomy ID | 49992 |
Linked level | species |
Family in NCBI taxonomy | Lamiaceae |
---|---|
ID | 4136 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Thymus vulgaris L. | Abortifacient |
Thymus vulgaris L. | Allergic |
Thymus vulgaris L. | Analgesic |
Thymus vulgaris L. | Antiallergic |
Thymus vulgaris L. | Antialzheimeran |
Thymus vulgaris L. | Antianaphylactic |
Thymus vulgaris L. | Antiarthritic |
Thymus vulgaris L. | Antibacterial |
Thymus vulgaris L. | Anticancer |
Thymus vulgaris L. | Anticariogenic |
Thymus vulgaris L. | Anticellulitis |
Thymus vulgaris L. | Anticomplementary |
Thymus vulgaris L. | Antiedemic |
Thymus vulgaris L. | Antienuretic |
Thymus vulgaris L. | Antiinflammatory |
Thymus vulgaris L. | Antimutagenic |
Thymus vulgaris L. | Antioxidant |
Thymus vulgaris L. | Antipyretic |
Thymus vulgaris L. | Antiseptic |
Thymus vulgaris L. | Antispasmodic |
Thymus vulgaris L. | Antithyroid |
Thymus vulgaris L. | Antitussive |
Thymus vulgaris L. | Antiulcer |
Thymus vulgaris L. | Aperitif |
Thymus vulgaris L. | Ascaricide |
Thymus vulgaris L. | Astringent |
Thymus vulgaris L. | Bronchospasmolytic |
Thymus vulgaris L. | Calcium Antagonist |
Thymus vulgaris L. | Carminative |
Thymus vulgaris L. | Choleretic |
Thymus vulgaris L. | Cicatrizant |
Thymus vulgaris L. | CNS Depressant |
Thymus vulgaris L. | COX-2 Inhibitor |
Thymus vulgaris L. | Decongestant |
Thymus vulgaris L. | Deodorant |
Thymus vulgaris L. | Dermatitigenic |
Thymus vulgaris L. | Diaphoretic |
Thymus vulgaris L. | Digestive |
Thymus vulgaris L. | Diuretic |
Thymus vulgaris L. | Emmenagogue |
Thymus vulgaris L. | Eupeptic |
Thymus vulgaris L. | Expectorant |
Thymus vulgaris L. | Fungicide |
Thymus vulgaris L. | Hyperemic |
Thymus vulgaris L. | Hypolipidemic |
Thymus vulgaris L. | Hypotensive |
Thymus vulgaris L. | Immunostimulant |
Thymus vulgaris L. | Insecticide |
Thymus vulgaris L. | Mucogenic |
Thymus vulgaris L. | Myorelaxant |
Thymus vulgaris L. | Nervine |
Thymus vulgaris L. | Pectoral |
Thymus vulgaris L. | Phagocytotic |
Thymus vulgaris L. | Respirosis |
Thymus vulgaris L. | Rubefacient |
Thymus vulgaris L. | Secretolytic |
Thymus vulgaris L. | Secretomotor |
Thymus vulgaris L. | Sedative |
Thymus vulgaris L. | Stimulant |
Thymus vulgaris L. | Tonic |
Thymus vulgaris L. | Tracheorelaxant |
Thymus vulgaris L. | Urinary Antiseptic |
Thymus vulgaris L. | Vermifuge |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004268
![]() |
Luteolin 7-glucuronide
/ Luteolin 7-O-glucuronide / Luteolin 7-O-beta-D-glucuronide |
CHEMBL464224
|
C075406
|
No. 2 | No. 15 |
![]() |
||
C00013595
![]() |
Eupatrin
/ Anisomelin / Fastigenin / Cirsilineol / 5,4'-Dihydroxy-6,7,3'-trimethoxyflavone |
CHEMBL487213
|
C057618
|
No. 3 | No. 15 |
![]() |
||
C00003931
![]() |
Thymonin
/ Majoranin / Mucroflavone B / 5,6,4'-Trihydroxy-7,8,3'-trimethoxyflavone / 5,6-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7,8-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL478416
|
No. 3 | No. 15 |
![]() |
|||
C00019064
![]() |
Oleanolic acid
/ Astrantiagenin C / Virgaureagenin B / 3beta-Hydroxyolean-12-en-28-oic acid |
CHEMBL56615
CHEMBL168 CHEMBL180553 CHEMBL365375 CHEMBL486382 CHEMBL1413646 CHEMBL1436454 |
D009828
|
30 / 8 / 12 | 21 / 15 | No. 13 | No. 51 |
![]() |
C00003558
![]() |
Ursolic acid
|
CHEMBL297810
CHEMBL56048 CHEMBL300594 CHEMBL169 CHEMBL176234 CHEMBL491715 CHEMBL1316667 CHEMBL1555307 CHEMBL1593360 CHEMBL1979720 |
C005466
|
47 / 26 / 33 | 15 / 12 | No. 13 | No. 51 |
![]() |
C00000960
![]() |
Eriodictyol
|
CHEMBL8996
CHEMBL307893 CHEMBL1975989 |
C007619
|
32 / 29 / 55 | 5 / 0 | No. 25 | No. 14 |
![]() |
C00000677
![]() |
Distylin
/ Dihydroquercetin / (2R,3R)-Taxifolin |
CHEMBL66
CHEMBL9249 CHEMBL337309 CHEMBL1492383 |
C003377
|
65 / 41 / 37 | 29 / 1 | No. 42 | No. 14 |
![]() |
C00002770
![]() |
Rosmarinic acid
|
CHEMBL66966
CHEMBL324842 CHEMBL1315100 CHEMBL2111558 |
48 / 35 / 38 | No. 749 |
![]() |
|||
C00000156
![]() |
Carvacrol
|
CHEMBL281202
|
C073316
|
10 / 6 / 1 | 4 / 2 | No. 969 | No. 35 |
![]() |
C00000155
![]() |
Thymol
|
CHEMBL29411
|
D013943
|
9 / 17 / 14 | 12 / 0 | No. 969 | No. 35 |
![]() |
C00000184
![]() |
alpha-Thujene
|
No. 1343 | No. 35 |
![]() |
||||
C00003040
![]() |
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
![]() |
||
C00010337
![]() |
cis-Myrcenol 8
/ (Z)-2-Methyl-6-methylene-2,7-octadien-1-ol |
No. 2285 | No. 34 |
![]() |
||||
C00003065
![]() |
Thymyl acetate
|
No. 3288 | No. 35 |
![]() |
||||
C00000842
![]() |
Bornyl acetate
|
CHEMBL1439452
|
4 / 1 / 4 | No. 4140 | No. 35 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00000677 C00000842 C00002770 C00003558 C00019064 | 1 / 4 |
P06746 | DNA polymerase beta | Enzyme | C00000677 C00000960 C00002770 C00003558 C00019064 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000677 C00000960 C00002770 C00003558 C00019064 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00000677 C00000842 C00002770 C00003558 C00019064 | 0 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000156 C00002770 C00003558 C00019064 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000677 C00000960 C00002770 C00003558 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000677 C00000842 C00000960 C00002770 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000677 C00000960 C00002770 C00003558 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000677 C00000960 C00002770 C00019064 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000842 C00002770 C00003558 C00019064 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000677 C00002770 C00003558 C00019064 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000155 C00002770 C00003558 C00019064 | 0 / 3 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000677 C00000960 C00002770 C00003558 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000677 C00002770 C00003558 | 1 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000677 C00000960 C00002770 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00000677 C00000960 C00002770 | 1 / 1 |
P15121 | Aldose reductase | Enzyme | C00002770 C00003558 C00019064 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000677 C00000960 C00019064 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000677 C00000960 C00002770 | 1 / 1 |
P39748 | Flap endonuclease 1 | Enzyme | C00000677 C00000960 C00002770 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000960 C00002770 C00003558 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000677 C00000960 C00002770 | 3 / 3 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000677 C00000960 C00002770 | 4 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000677 C00000960 C00002770 | 2 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000677 C00002770 C00003558 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000677 C00002770 C00003558 | 1 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002770 C00003558 C00019064 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000677 C00003558 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000155 C00003558 | 11 / 10 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000960 C00002770 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000677 C00003558 | 2 / 5 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00002770 C00003558 | 3 / 1 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000677 C00003558 | 1 / 2 |
P24666 | Low molecular weight phosphotyrosine protein phosphatase | Tyr | C00003558 C00019064 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000677 C00000960 | 0 / 0 |
P10586 | Receptor-type tyrosine-protein phosphatase F | Receptor tyrosine-protein phosphatase | C00003558 C00019064 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00003558 C00019064 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00000677 C00002770 | 1 / 2 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003558 C00019064 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000677 C00002770 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000155 C00000156 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002770 C00019064 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000155 C00000156 | 5 / 1 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000155 C00000156 | 1 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000155 C00000156 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00000677 C00000960 | 1 / 1 |
P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00003558 C00019064 | 0 / 1 |
P29350 | Tyrosine-protein phosphatase non-receptor type 6 | Tyr | C00003558 C00019064 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003558 C00019064 | 0 / 0 |
P23469 | Receptor-type tyrosine-protein phosphatase epsilon | Receptor tyrosine-protein phosphatase | C00003558 C00019064 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000155 C00000156 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000155 C00000156 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000677 C00000960 | 0 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00000960 C00002770 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003558 C00019064 | 0 / 0 |
P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00003558 C00019064 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000677 C00002770 | 0 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003558 C00019064 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000677 C00002770 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00003558 C00019064 | 2 / 2 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002770 C00003558 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000155 C00000156 | 3 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00000677 C00000960 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002770 | 0 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000960 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00000960 | 4 / 4 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00002770 | 0 / 0 |
P45452 | Collagenase 3 | M10A | C00000677 | 1 / 1 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00000677 | 2 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00003558 | 0 / 0 |
O15379 | Histone deacetylase 3 | Hydrolase | C00003558 | 0 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002770 | 1 / 2 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00019064 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000677 | 0 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000960 | 0 / 1 |
P56817 | Beta-secretase 1 | A1A | C00000677 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000677 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00000677 | 1 / 3 |
Q9UQL6 | Histone deacetylase 5 | Hydrolase | C00003558 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00000677 | 1 / 1 |
P51692 | Signal transducer and activator of transcription 5B | Unclassified protein | C00002770 | 1 / 1 |
P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00003558 | 1 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000960 | 0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000677 | 5 / 2 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00000960 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000156 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000677 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000960 | 1 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000677 | 0 / 0 |
P56524 | Histone deacetylase 4 | Hydrolase | C00003558 | 1 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002770 | 1 / 0 |
P30305 | M-phase inducer phosphatase 2 | Ser_Thr_Tyr | C00003558 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002770 | 0 / 0 |
P35228 | Nitric oxide synthase, inducible | Enzyme | C00019064 | 1 / 1 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00019064 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00000960 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000677 | 1 / 1 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003558 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000677 | 0 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00000677 | 0 / 0 |
Q13547 | Histone deacetylase 1 | Hydrolase | C00003558 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000677 | 2 / 2 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00003558 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000960 | 3 / 1 |
P39900 | Macrophage metalloelastase | M10A | C00000677 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00000677 | 1 / 0 |
Q9UBN7 | Histone deacetylase 6 | Hydrolase | C00003558 | 0 / 0 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00019064 | 4 / 2 |
P04054 | Phospholipase A2 | Enzyme | C00019064 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003558 | 1 / 1 |
Q12794 | Hyaluronidase-1 | Enzyme | C00002770 | 1 / 2 |
P04062 | Glucosylceramidase | Enzyme | C00002770 | 6 / 4 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002770 | 3 / 0 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000677 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000677 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000677 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002770 | 3 / 3 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000677 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002770 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003558 | 1 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00000677 | 2 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000156 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000677 | 4 / 1 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00002770 | 0 / 0 |
Q05513 | Protein kinase C zeta type | Iota | C00000677 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00000677 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00000677 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00000677 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000677 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00000677 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00000677 | 1 / 1 |
P05771 | Protein kinase C beta type | Alpha | C00000677 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00000677 | 1 / 0 |
P41743 | Protein kinase C iota type | Iota | C00000677 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00000677 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000960 | 7 / 37 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00002770 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00000960 | 2 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000155
C00000156
C00003558
C00019064
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000677
C00000960
C00019064
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000677
C00003558
C00019064
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000155
C00003558
C00019064
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000155
C00003558
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00003558
C00019064
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00000677
C00000960
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000155
C00003558
|
9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00000155
C00003558
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00003558
C00019064
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000155
C00000156
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000677
C00000960
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00019064
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00000677
|
2621 | GAS6, AXLLG, AXSF | growth arrest-specific 6 |
C00000677
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00000677
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000677
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000677
|
4547 | MTTP, ABL, MTP | microsomal triglyceride transfer protein |
C00000677
|
2248 | FGF3, HBGF-3, INT2 | fibroblast growth factor 3 |
C00000677
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000677
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00000677
|
5921 | RASA1, CM-AVM, CMAVM, GAP, PKWS, RASA, RASGAP, p120GAP, p120RASGAP | RAS p21 protein activator (GTPase activating protein) 1 |
C00000677
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000677
|
7187 | TRAF3, CAP-1, CAP1, CD40bp, CRAF1, IIAE5, LAP1 | TNF receptor-associated factor 3 |
C00000677
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000677
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00000677
|
7507 | XPA, XP1, XPAC | xeroderma pigmentosum, complementation group A |
C00000677
|
7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
C00000677
|
8817 | FGF18, FGF-18, ZFGF5 | fibroblast growth factor 18 |
C00000677
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00003558
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00000677
|
1630 | DCC, CRC18, CRCR1, IGDCC1, MRMV1 | deleted in colorectal carcinoma |
C00000677
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000677
|
993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00000677
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00003558
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00003558
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00003558
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00003558
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00003558
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00003558
|
8900 | CCNA1 | cyclin A1 |
C00000677
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00000677
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000960
|
29110 | TBK1, NAK, T2K | TANK-binding kinase 1 (EC:2.7.11.1) |
C00000960
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00000156
|
335 | APOA1 | apolipoprotein A-I |
C00000677
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000156
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00019064
|
847 | CAT | catalase (EC:1.11.1.6) |
C00019064
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00019064
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000677
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00019064
|
3065 | HDAC1, GON-10, HD1, RPD3, RPD3L1 | histone deacetylase 1 (EC:3.5.1.98) |
C00019064
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00019064
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00019064
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00019064
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00019064
|
5052 | PRDX1, MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB, PRX1, PRXI, TDPX2 | peroxiredoxin 1 (EC:1.11.1.15) |
C00019064
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00019064
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00019064
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00019064
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00019064
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000155
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000155
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000155
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000155
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000155
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000155
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#600807 | Asthma, susceptibility to |
Q13093
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#600430 | Brachydactyly-mental retardation syndrome; bdmr |
P56524
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P18054
Q14191 |
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#133239 | Esophageal cancer |
P04637
P18054 |
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#211980 | Lung cancer |
P04637
|
#611162 | Malaria, susceptibility to |
P35228
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P24723
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00028 | Choriocarcinoma |
P03956
(related)
P04637 (related) P08253 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35228 (related) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00408 | Type I diabetes mellitus |
P17706
(related)
Q04759 (related) |
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00561 | Brachydacytly-mental retardation syndrome and Smith-Magenis syndrome |
P56524
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006949 | Hyperlipidemias |
C00003558
C00019064 |
D009369 | Neoplasms |
C00003558
C00019064 |
D017202 | Myocardial Ischemia |
C00003558
C00019064 |
D008103 | Liver Cirrhosis |
C00003558
C00019064 |
D007249 | Inflammation |
C00003558
C00019064 |
D012878 | Skin Neoplasms |
C00003558
|
D006461 | Hemolysis |
C00000677
|
D006965 | Hyperplasia |
C00003558
|
D003921 | Diabetes Mellitus, Experimental |
C00003558
|
D002471 | Cell Transformation, Neoplastic |
C00003558
|
D006528 | Carcinoma, Hepatocellular |
C00003558
|
D001284 | Atrophy |
C00003558
|
D006943 | Hyperglycemia |
C00003558
|
D003866 | Depressive Disorder |
C00000156
|
D010146 | Pain |
C00000156
|
D002252 | Carbon Tetrachloride Poisoning |
C00019064
|
D056486 | Drug-Induced Liver Injury |
C00019064
|
D050171 | Dyslipidemias |
C00019064
|
D018149 | Glucose Intolerance |
C00019064
|
D007674 | Kidney Diseases |
C00019064
|
D008106 | Liver Cirrhosis, Experimental |
C00019064
|
D008107 | Liver Diseases |
C00019064
|
D009765 | Obesity |
C00019064
|
D011041 | Poisoning |
C00019064
|
D011230 | Precancerous Conditions |
C00019064
|